2025
SJR Q1
JCR Q3 · 2
OA
SCIE
Journal detail
AIDS Reviews
- Publisher
- Permanyer Publications
- Country
- Spain · Western Europe
- Type
- journal
- ISSN
-
1139612116986997
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,972
- Quartile Q1
- H-Index 64
- Cites/doc 1,62
- Docs (3y) 74
- Cites (3y) 146
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 2
- JCI 0,39
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Infectious Diseases Q2
- Medicine (miscellaneous) Q1
- Pharmacology (medical) Q1
Areas
- Medicine
WoS categories
- Immunology | Infectious Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q3 | 0,972 | 2 | 2 | 0,39 | Q4 | 64 |
| 2024 | Q3 | Q2 | 0,491 | 2,5 | 2,1 | 0,42 | Q3 | 63 |
| 2023 | Q3 | Q3 | 0,445 | 1,9 | 2,1 | 0,36 | Q3 | 63 |
| 2022 | Q2 | Q4 | 0,593 | 2,2 | 2,1 | 0,33 | Q4 | 63 |
| 2021 | Q3 | Q4 | 0,489 | 2,4 | 2,3 | 0,29 | Q4 | 63 |
| 2020 | Q2 | Q3 | 0,605 | 2,5 | 2,5 | 0,37 | Q4 | 63 |
| 2019 | Q2 | Q3 | 0,752 | 2,3 | 2,2 | 0,38 | Q4 | 63 |
| 2018 | — | Q3 | — | 2,4 | 2,5 | 0,41 | Q3 | — |
| 2017 | Q1 | Q2 | 1,118 | 2,8 | 2,9 | 0,47 | Q3 | 63 |
| 2016 | Q1 | Q2 | 1,372 | 3,2 | 3,2 | — | — | 63 |
| 2015 | Q1 | Q3 | 1,274 | 2,1 | 2,9 | — | — | 63 |
| 2014 | Q1 | Q2 | 1,764 | 3,8 | 3,6 | — | — | 63 |
| 2013 | Q1 | Q1 | 1,727 | 4 | 3,8 | — | — | 63 |
| 2012 | Q1 | Q1 | 1,661 | 4,1 | 4 | — | — | 63 |
| 2011 | Q1 | Q2 | 1,932 | 3,5 | 3,9 | — | — | 63 |
| 2010 | Q1 | Q1 | 1,964 | 4,8 | 4,1 | — | — | 63 |
| 2009 | — | Q1 | — | 3,8 | 3,7 | — | — | — |
| 2008 | — | Q2 | — | 3,3 | — | — | — | — |
| 2007 | — | Q1 | — | 3,7 | — | — | — | — |
| 2006 | — | Q1 | — | 4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q4 | Q4 | 149/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q3 | Q4 | 100/141 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q4 | 122/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q2 | Q3 | 68/137 |
| 2023 | IMMUNOLOGY | SCIE | Q4 | Q4 | 147/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 90/132 |
| 2022 | IMMUNOLOGY | SCIE | Q4 | Q4 | 137/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 76/96 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q4 | 140/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 79/95 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q4 | 131/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q3 | Q4 | 67/93 |
| 2019 | IMMUNOLOGY | SCIE | Q4 | Q4 | 120/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q3 | Q4 | 61/92 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q4 | 119/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 53/89 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q4 | 91/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q2 | Q3 | 40/88 |
| 2016 | IMMUNOLOGY | SCIE | Q2 | — | 66/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q2 | — | 27/84 |
| 2015 | IMMUNOLOGY | SCIE | Q4 | — | 114/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q3 | — | 52/83 |
| 2014 | IMMUNOLOGY | SCIE | Q2 | — | 46/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q2 | — | 22/78 |
| 2013 | IMMUNOLOGY | SCIE | Q2 | — | 39/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q1 | — | 15/72 |
| 2012 | IMMUNOLOGY | SCIE | Q1 | — | 34/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q1 | — | 13/70 |
| 2011 | IMMUNOLOGY | SCIE | Q2 | — | 48/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q2 | — | 20/70 |
| 2010 | IMMUNOLOGY | SCIE | Q1 | — | 23/134 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/58 |
| 2009 | IMMUNOLOGY | SCIE | Q2 | — | 33/128 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q1 | — | 12/57 |
| 2008 | IMMUNOLOGY | SCIE | Q2 | — | 43/121 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q2 | — | 13/51 |
| 2007 | IMMUNOLOGY | SCIE | Q2 | — | 34/119 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q1 | — | 11/50 |
| 2006 | IMMUNOLOGY | SCIE | Q1 | — | 25/117 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/47 |